Displaying 1 to 20 of 45 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Achillion Pharmaceuticals Inc Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Amicus Therapeutics Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Arginetix Inc Biopharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase. |
United States | 1 Oct 2008 | Seed |
|
|
|
Argolyn Bioscience Inc Peptide drug developer. |
United States | N/A |
||
|
|
BioLeap LLC |
United States | N/A |
||
|
|
Biolex Therapeutics Inc |
United States | 1 Sep 2005 | Series B Active |
|
|
|
Biolex Therapeutics Inc |
United States | 1 May 2007 | Series C Active |
|
|
|
Biolex Therapeutics Inc |
United States | 1 Oct 2008 | Series D Active |
|
|
|
BioRexis Pharmaceutical Corp |
United States | N/A |
||
|
|
Celator Pharmaceuticals Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. |
United States | 1 Sep 2010 | Series D Active |
|
|
|
Celator Pharmaceuticals Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. |
United States | 1 May 2005 | N/A Active |
|
|
|
Celator Pharmaceuticals Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. |
United States | 1 Jul 2008 | Series C Active |
|
|
|
Cellatope Corp |
United States | N/A |
||
|
|
Cempra Inc Developer of a drugs for difficult-to-treat and drug-resistant bacterial infections. |
United States | N/A |
||
|
|
Corridor Pharmaceuticals Inc |
United States | N/A |
||
|
|
Diasome Pharmaceuticals Uses Hepatocyte Directed Vesicles to deliver insulin for diabetes treatment |
United States | N/A |
||
|
|
Discovery Laboratories Inc Biotechnology company focused on advancing a new standard in respiratory critical care through the development of novel technologies. |
United States | N/A |
||
|
|
EKR Therapeutics Inc |
United States | N/A |
||
|
|
Eximias Pharmaceutical Corp Developing late stage cancer therapeutics. |
United States | N/A |
||
|
|
INSMED Inc Biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology. |
United States | N/A |